# Efficacy and Safety of Top-down Therapy in Pediatric Crohn's Disease

> **NCT01752790** · PHASE4 · WITHDRAWN · sponsor: **University of Roma La Sapienza**

## Conditions studied

- Pediatric Crohn's Disease

## Interventions

- **DRUG:** Top-down
- **DRUG:** Step-up

## Key facts

- **NCT ID:** NCT01752790
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-12
- **Primary completion:** 2014-01
- **Final completion:** 2015-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study will be part of a European multicenter trial (Infliximab Top-down Study in Kids with Crohn's disease)
- **Last updated:** 2013-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01752790

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01752790, "Efficacy and Safety of Top-down Therapy in Pediatric Crohn's Disease". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01752790. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*